EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Catatonia responsive to corticosteroids in a patient with an SCN2A variant

Kimberly Senko iD, Kelsey L Saddoris iD, Ella Baus, Katherine Soe iD, Samuel E Vaughn iD

American Journal of Medical Genetics Part C: Seminars in Medical Genetics · 2024

DOI: 10.1002/ajmg.c.32101 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2024. Verfasst von Kimberly Senko und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: NAV1.2 Voltage-Gated Sodium Channel, Catatonia, Autism Spectrum Disorder, Adrenal Cortex Hormones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Variants in SCN2A are a known risk factor for developing autism spectrum disorder (ASD). Catatonia is a complex neuropsychiatric syndrome, which occurs at a higher rate in individuals with ASD. Catatonia has also been associated with COVID‐19 infection, though the majority of these cases are associated with increased serum inflammatory markers. We present a case of a 15‐year‐old female with ASD and corticosteroid responsive stuporous catatonia to explore the relationship between SCN2A variants, ASD, COVID‐19 exposure, and treatment refractory catatonia. Despite a lack of significantly elevated serum or CSF inflammatory markers, this patient showed significant improvement following initiation of corticosteroid therapy. This case presents a novel approach to the work‐up and treatment of catatonia in individuals with SCN2A variants independent of elevated inflammatory markers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NAV1.2 Voltage-Gated Sodium ChannelCatatoniaAutism Spectrum DisorderAdrenal Cortex HormonesHumansFemaleAdolescentCOVID-19SARS-CoV-2

Stichwörter der Autor:innen

COVID‐19SCN2Aautismcatatoniasteroids

Substanzen

NAV1.2 Voltage-Gated Sodium ChannelSCN2A protein, humanAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Division of Child & Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Division of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

ORCID-Profile: Kimberly Senko, Kelsey L Saddoris, Katherine Soe, Samuel E Vaughn

Zitieren

APA

Senko, K., Saddoris, K. L., Baus, E., Soe, K., & Vaughn, S. E. (2024). Catatonia responsive to corticosteroids in a patient with an SCN2A variant. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.32101

Vancouver

Senko K, Saddoris KL, Baus E, Soe K, Vaughn SE. Catatonia responsive to corticosteroids in a patient with an SCN2A variant. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2024. doi:10.1002/ajmg.c.32101

BibTeX
@article{Senko2024,
  author = {Senko, Kimberly and Saddoris, Kelsey L and Baus, Ella and Soe, Katherine and Vaughn, Samuel E},
  title = {Catatonia responsive to corticosteroids in a patient with an SCN2A variant},
  journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
  year = {2024},
  doi = {10.1002/ajmg.c.32101}
}
Kostenlos starten →